rs8075575
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000570780.5(GPS2):c.969+538A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0149 in 434,412 control chromosomes in the GnomAD database, including 352 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.034 ( 283 hom., cov: 32)
Exomes 𝑓: 0.0045 ( 69 hom. )
Consequence
GPS2
ENST00000570780.5 intron
ENST00000570780.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.175
Publications
3 publications found
Genes affected
GPS2 (HGNC:4550): (G protein pathway suppressor 2) This gene encodes a protein involved in G protein-mitogen-activated protein kinase (MAPK) signaling cascades. When overexpressed in mammalian cells, this gene could potently suppress a RAS- and MAPK-mediated signal and interfere with JNK activity, suggesting that the function of this gene may be signal repression. The encoded protein is an integral subunit of the NCOR1-HDAC3 (nuclear receptor corepressor 1-histone deacetylase 3) complex, and it was shown that the complex inhibits JNK activation through this subunit and thus could potentially provide an alternative mechanism for hormone-mediated antagonism of AP1 (activator protein 1) function. [provided by RefSeq, Jul 2008]
EIF5A (HGNC:3300): (eukaryotic translation initiation factor 5A) Enables U6 snRNA binding activity and protein N-terminus binding activity. Involved in several processes, including cellular response to virus; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; and tumor necrosis factor-mediated signaling pathway. Located in annulate lamellae; cytoplasm; and nucleus. Part of nuclear pore. [provided by Alliance of Genome Resources, Apr 2022]
EIF5A Gene-Disease associations (from GenCC):
- Faundes-Banka syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.115 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GPS2 | ENST00000380728.7 | c.*265A>G | downstream_gene_variant | 1 | NM_004489.5 | ENSP00000370104.2 | ||||
| EIF5A | ENST00000336458.13 | c.*681T>C | downstream_gene_variant | 1 | NM_001970.5 | ENSP00000336776.8 | ||||
| ENSG00000261915 | ENST00000575474.1 | n.*1524A>G | downstream_gene_variant | 5 | ENSP00000468772.1 |
Frequencies
GnomAD3 genomes AF: 0.0341 AC: 5188AN: 152010Hom.: 279 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5188
AN:
152010
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00450 AC: 1271AN: 282284Hom.: 69 Cov.: 0 AF XY: 0.00376 AC XY: 557AN XY: 148174 show subpopulations
GnomAD4 exome
AF:
AC:
1271
AN:
282284
Hom.:
Cov.:
0
AF XY:
AC XY:
557
AN XY:
148174
show subpopulations
African (AFR)
AF:
AC:
920
AN:
8330
American (AMR)
AF:
AC:
68
AN:
10942
Ashkenazi Jewish (ASJ)
AF:
AC:
56
AN:
8862
East Asian (EAS)
AF:
AC:
0
AN:
17934
South Asian (SAS)
AF:
AC:
8
AN:
30908
European-Finnish (FIN)
AF:
AC:
0
AN:
20110
Middle Eastern (MID)
AF:
AC:
10
AN:
1198
European-Non Finnish (NFE)
AF:
AC:
54
AN:
167506
Other (OTH)
AF:
AC:
155
AN:
16494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
50
100
149
199
249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0343 AC: 5213AN: 152128Hom.: 283 Cov.: 32 AF XY: 0.0330 AC XY: 2456AN XY: 74374 show subpopulations
GnomAD4 genome
AF:
AC:
5213
AN:
152128
Hom.:
Cov.:
32
AF XY:
AC XY:
2456
AN XY:
74374
show subpopulations
African (AFR)
AF:
AC:
4868
AN:
41462
American (AMR)
AF:
AC:
228
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
24
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5172
South Asian (SAS)
AF:
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
42
AN:
68000
Other (OTH)
AF:
AC:
46
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
233
465
698
930
1163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
28
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.